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SUMMARY  18 
Over the past several decades, outbreaks of emerging infectious diseases (EIDs) in wild birds 19 
have attracted worldwide media attention, either because of their extreme virulence or because of 20 
alarming spillovers into agricultural animals or humans. The pathogens involved have been 21 
found to infect a variety of bird hosts ranging from relatively few species (e.g., Trichomonas 22 
gallinae) to hundreds of species (e.g., West Nile Virus). Here we review and contrast the 23 
immune responses that wild birds are able to mount against these novel pathogens. We discuss 24 
the extent to which these responses are associated with reduced clinical symptoms, pathogen 25 
load and mortality, or conversely, how they are sometimes linked to worsened pathology and 26 
reduced survival. We then investigate how immune responses to EIDs can evolve over time in 27 
response to pathogen-driven selection using the illustrative case study of the epizootic outbreak 28 
of Mycoplasma gallisepticum in wild North American house finches (Haemorhous mexicanus). 29 
We highlight the need for future work to take advantage of the substantial inter- and intra-30 
specific variation in disease progression and outcome following infections with EID to elucidate 31 
the extent to which immune responses confer increased resistance through pathogen clearance or 32 
may instead heighten pathogenesis.   33 
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INTRODUCTION 34 
The drastic impact that infectious diseases can have on their hosts is illustrated in humans by 35 
records of mortality rates resulting from outbreaks like the Spanish flu pandemic of 1918-20 (1), 36 
as well as more recently by evidence of the role of pathogens in shaping our genome (2, 3). 37 
Emerging and re-emerging infectious diseases (EIDs), which include novel diseases that have 38 
spread to a new host species or population and historical diseases which have rapidly increased 39 
in incidence (4), are particularly strong selection events (5). They can therefore pose significant 40 
threats to wild populations through loss of genetic diversity, population declines, and even 41 
localised extinctions of already endangered species (6, 7). Given that risks of disease 42 
(re)emergence are thought to be aggravated by anthropogenic factors, ranging from our intensive 43 
farming practices to the increased movement of organisms across the globe (8), it is now urgent 44 
to improve our understanding of how hosts respond to novel diseases and how immune processes 45 
evolve subsequently.  46 
 47 
Over the past century, wild birds have been subject to devastating, yet well-documented, wildlife 48 
epizootics (Box 1) (9-14), making them valuable models for studying host immune responses to 49 
EIDs, as well as how pathogen-driven selection shapes the evolution of host immunity. For 50 
example, between December 2002 and January 2003, Hong Kong saw large die-offs of new and 51 
old world species of ducks, geese, and swans from Highly Pathogenic Avian Influenza (HPAI) 52 
(15), Great Britain lost over half a million greenfinches (Carduelis chloris) and chaffinches 53 
(Fringilla coelebs) within two years of the emergence of Trichomonas gallinae (13, 16), and an 54 
estimated hundreds of millions of house finches (Haemorhous mexicanus) in the eastern United 55 
States died following the Mycoplasma gallisepticum epizootic that began in 1994 (9, 17, 18). 56 
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Similarly, the emergence of West Nile Virus (WNV) in New York (NY) in 1999 was 57 
accompanied by more than 17,000 dead bird sightings between May and November of that year, 58 
one-third of which were American crows (Corvus brachyrhynchos) (19). The causal role of 59 
disease in these observed mortality rates was confirmed through testing of carcasses and sick 60 
individuals (19, 20) followed by experimental infection studies (21-24). American crows 61 
experimentally infected with the NY-1999 WNV strain exhibited 100% mortality with severe 62 
clinical symptoms before death, including anorexia, weight loss, encephalitis, and oral and/or 63 
cloacal hemorrhaging (21, 22). Likewise, experimental infection with the H5N1 strain of HPAI 64 
resulted in 100% mortality of black swans (Cygnus atratus), mute swans (Cygnus olor), 65 
trumpeter swans (Cygnus buccinator), whooper swans (Cygnus cygnus) (23) and Canada geese 66 
(Branta canadensis)
 
(24). Of these, some black swans died without ever exhibiting clinical 67 
symptoms, while the remaining black swans and mute swans died less than 24 hours after the 68 
onset of clinical symptoms that progressively worsened from mild listlessness to severe 69 
neurological symptoms including tremors and seizures (23). The severe impact that recent EID 70 
outbreaks have had on wild avian hosts therefore raises the question of these hosts’ ability to 71 
mount immune responses to novel pathogens, as well as the extent to which immune responses 72 
may have allowed the host to fight off and/or clear the infection (25). 73 
 74 
Despite the high mortality rates observed following these EID outbreaks, there appears to be 75 
marked variation in disease development and outcome among and within host species (22, 26). 76 
For example, between 2007-2010, wild-caught individuals from 27 of 53 bird species were found 77 
to be or to have been infected with M. gallisepticum based on PCR and/or testing of serum for 78 
antibodies via rapid plate agglutination, but only house finches (Haemorhous mexicanus), 79 
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American goldfinches (Spinus tristis), purple finches (Haemorhous purpureus) and black-capped 80 
chickadees (Poecile atricapillus) exhibited conjunctivitis (26). Experimental infections with NY-81 
1999 WNV of 25 species of birds representing 17 orders also revealed inter-specific differences 82 
with mean peak viremias ranging from 10^2.8 to 10^12.1 PFU/ml, as well as highly variable 83 
mortality, even amongst species with the greatest viremias (22). In fact, in the same study, 84 
pathogen load did not necessarily predict disease outcome: although American crows had 100% 85 
mortality with a mean peak viremia of 10^10.2 PFU/ml, three other species, common grackles 86 
(Quiscalus quiscula), house sparrows (Passer domesticus), and blue jays (Cyanocitta cristata), 87 
reached higher mean viremias yet exhibited mortalities of only 33%, 50%, and 75%, respectively 88 
(22). Variation in disease progression and mortality is found not only among species but also 89 
within species, even in those species that display noticeably high mortality rates (27-30). For 90 
example, the emergence of Plasmodium relictum in the Hawaiian islands following the 91 
accidental introduction of its mosquito vector (Culex quinquefasciatus) in the early 20
th
 century 92 
was devastating to populations of some native Hawaiian species, particularly Hawaiian 93 
honeycreepers such as the apapane (Himatione sanguinea), Hawaii amakihi (Hemignathus 94 
virens), and iiwi (Vestiaria coccinea) (14, 31). Yet experimental exposure of those species to P. 95 
relictum revealed that some individuals survived and those that did displayed lower levels of 96 
infected circulating erythrocytes and lost less mass than birds that died from the infection (28-97 
30). Despite clear evidence of inter- and intra-specific variation in susceptibility to EIDs, our 98 
understanding of the precise immune mechanisms by which this variation is achieved remains 99 
incomplete. 100 
 101 
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Here we review the immune responses that are mounted by wild birds to EIDs using data 102 
garnered from field studies of live birds and carcasses, as well as laboratory-conducted 103 
experimental infections. First, we examine the types of immune responses wild birds are able to 104 
mount against novel pathogens at the cellular and molecular level, as well as evaluate how inter- 105 
and intra-specific variation in immunity can be linked to variation in disease severity and 106 
outcome. Examining such variation is essential for identifying the immune processes associated 107 
with differences in disease development and outcome as well as predicting whether and how 108 
these immune responses may evolve over time. Finally, we build on the well-documented 109 
epizootic outbreak of Mycoplasma gallisepticum in North American house finches to illustrate 110 
how immune responses can evolve in natural avian populations in response to novel diseases.  111 
 112 
IMMUNE RESPONSES OF WILD BIRDS TO EIDS 113 
 114 
Evidence from both field and laboratory studies indicate that some individuals are able to mount 115 
immune responses against EIDs and that these responses may confer long term protection against 116 
secondary exposures. For example, experimental infections of American kestrels (Falco 117 
sparverius) and dunlin (Calidris alpina) with H5N1 HPAI revealed that birds seroconverted and 118 
produced detectable levels of specific antibodies by 4 to 5 days post-infection (dpi) (32, 33). 119 
Similarly, experimental infection of laughing gulls (Leucophaeus atricilla) with H5N1 HPAI 120 
revealed that the 2 out of 6 individuals that survived infection produced antibodies against HPAI 121 
(27). In addition, these two surviving individuals had no gross lesions at necropsy and only mild 122 
encephalitis and pancreatitis due to lymphocytic and heterophilic infiltration, respectively. In 123 
contrast, laughing gulls following infection displayed more severe pathology including 124 
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widespread petechial hemorrhaging, necrotizing pancreatitis, cerebral neuronal necrosis, and 125 
necrotizing adrenalitis (27). This suggests that the humoral response mounted by the two 126 
surviving laughing gulls is likely to have enabled them to limit or even clear the infection. Such 127 
production of specific antibodies has been found to persist, giving rise to stronger adaptive 128 
immune responses upon re-infection. For instance, wild-caught rock pigeons (Columba livia) 129 
that had been naturally infected with WNV produced antibodies against the virus for at least 15 130 
months after capture (34). Similarly, WNV antibodies have been shown to persist in fish crows 131 
(Corvus ossifragus) for at least 12 months (35) and in various raptors for at least four years (36), 132 
while house sparrows experimentally infected with WNV had detectable antibodies for up to 36 133 
months (37). When re-challenged with WNV at 6, 12, 24, or 36 months post-infection, 52 of 71 134 
house sparrows exhibited ≥ 4-fold increases in antibody titers and only one individual re-135 
challenged at 12 months post-infection became viremic; all individuals given a primary 136 
challenge, in contrast, became viremic (37). In the same way, house finches experimentally re-137 
infected with M. gallisepticum 219, 314, or 425 days after the primary infection showed reduced 138 
conjunctival swelling and duration of clinical symptoms from day 7 dpi onwards relative the 139 
response they exhibited upon primary exposure (38).  140 
 141 
Differences in the intensity and duration of humoral immune responses to EID may also be 142 
associated with variation in disease progression and outcome between avian host species. 143 
Experimental infections of American crows and fish crows with WNV revealed that fish crows 144 
showed milder and delayed clinical symptoms and lower pathogen loads, and exhibited peak 145 
viremias of 10^4.7-6.3 PFU/ml at 3-4 dpi that declined to 10^1.7-2.2 PFU/ml by 6 dpi, whereas 146 
American crows had peak viremias of 10^8.22-9.6 at 4-5 dpi that were still high (10^7.3-7.7) at 6 147 
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dpi (39). Individuals from both species seroconverted at 5 dpi, but fish crows displayed a greater 148 
antibody production that went from 87-90% WNV serum neutralizing activity at 5 dpi to 93-149 
100% at 6 dpi, while antibody production was lower in American crows with only 41-69% WNV 150 
neutralizing activity at 5 dpi and 69-79% at 6 dpi (39). Taken together, these results suggest that 151 
the stronger antibody response of fish crows to WNV may explain their increased ability to resist 152 
WNV infection relative to American crows (Figure 1). Whether this is truly the case is unclear, 153 
and explicit links between the intensity of humoral immune responses to EIDs, variation in 154 
pathogen load, disease development and outcome remain to be explored further. 155 
 156 
The immune responses of wild birds to EIDs do not, however, necessarily give rise to decreased 157 
disease severity and a greater ability to clear infection, but may instead be associated with a 158 
worsening of clinical symptoms through immunopathology (for example see (40, 41)). This may 159 
be particularly true when infections trigger the activation of an inflammatory response, which 160 
can damage host tissue and mediate pathogenesis (42, 43). Damage from inflammation was, for 161 
e.g., found in HPAI-infected wood ducks (Aix sponsa) and laughing gulls that exhibited air 162 
sacculitis due to heterophil, lymphocyte, and plasma cell infiltration (27). Geese and swans also 163 
displayed mild to moderate heterophilic and lymphoplasmacytic inflammation in locations where 164 
HPAI antigen was detected (23). HPAI-infected tufted ducks (Aythya fuligula) exhibited 165 
encephalitis symptoms that upon necropsy were attributed to gliosis, neuronophagia, and 166 
inflammatory lesions associated with macrophage and lymphocyte infiltration (40). Furthermore, 167 
heterophilic infiltration was observed throughout the respiratory system of these individuals, yet 168 
there was no inflammation associated with the virus in the intestines
 
(40). Patterns of 169 
inflammatory responses associated with sites of EID antigen localization have been observed 170 
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following both WNV and T. gallinae infections (16, 41, 44, 45). For instance, in response to 171 
WNV, both blue jays and American crows displayed mixed inflammatory reactions and spleen 172 
congestion due to inflammatory cell aggregates and fibrin deposition in areas of inflammation 173 
(44). Inflammation in wild finches that succumbed to T. gallinae infections in Canada (purple 174 
finches) and Great Britain (greenfinches and chaffinches) was found to result from mixed 175 
responses of heterophils, macrophages, and lymphocytes (16, 41). Such inflammatory responses 176 
were also responsible for the mucosal thickening seen in T. gallinae–infected greenfinches and 177 
chaffinches in Fennoscandia (45). Finally, post-mortem examination of wild birds naturally 178 
infected with H5N1 revealed variation in the distribution and severity of the inflammation of the 179 
brain, with species exhibiting some of the highest mortality rates from infection (i.e., swans and 180 
geese) also displaying the most severe encephalitis, while other species typically showed only 181 
mild to moderate encephalitis (Figure 2) (23, 27, 46-48). All these examples suggest that, in 182 
some cases, immune responses (i.e., inflammation) may be detrimental to the host and 183 
mediate/accelerate disease progression and outcome. Further support for such a hypothesis 184 
comes from the fact that pathogens have been found to benefit from activating inflammatory 185 
responses, for e.g., when inflammation disrupts host tissues and facilitates the infiltration and 186 
spread of the pathogen (49). Such damages incurred as a result of immune responsiveness are 187 
expected to have important consequences for the evolution of immunity to EIDs, with 188 
individuals that remain non-responsive or activate other components of the immune system being 189 
favoured over time. 190 
 191 
While our understanding of the immune responses to EIDs in wild birds mainly consists of 192 
measures of antibody production or inflammation, investigations into the transcriptomic changes 193 
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following controlled experimental infection reveal a more complex picture. Huang and 194 
colleagues recently compared the global gene expression profiles of lungs from mallards (Anas 195 
platyrhynchos) infected with H5N1 HPAI to control individuals at 1, 2, and 3 dpi (50). The 196 
number of differentially expressed genes ranged from 2,257 to 3,066, depending on the day of 197 
measurement post-infection and analysis of these genes revealed complex expression patterns of 198 
genes known to play roles in immunity. For example, H5N1-infected ducks showed a marked 199 
increase (between 2 and 1,414-fold) in the expression of five interferon (IFN), 10 chemokine, 200 
and 10 interleukin (IL) or IL-receptor genes. The expression of genes known to be involved in 201 
the mammalian response to avian influenza and thought to be involved in the avian response 202 
including DDX58, IFITM3 and IFIT1–IFIT3, increased between 6.9 and 440-fold, peaking at 2 203 
dpi (50). Additionally, mallards exhibited increased expression of two RNA helicases, IFN-204 
induced proteins, toll-like receptors (TLRs), and major histocompatibility complex (MHC) 205 
genes. In contrast, other genes, including immunoglobulin M (IgM), three T-cell receptor (TCR) 206 
genes, and 4 CD molecule-encoding genes were shown to have decreased expression (50). Taken 207 
together, these data suggest EIDs elicit altered expression of multiple immune pathways in 208 
infected avian hosts.  209 
 210 
Such a hypothesis of multiple immune pathways being involved in the responses of wild birds to 211 
EIDs is further supported by analyses of H5N1 HPAI-infected jungle crow (Corvus 212 
macrorhynchos) lung transcriptomes at 6 dpi, which revealed significant differential expression 213 
of 2,297 genes between infected and control individuals. Based on gene ontology analysis, the 214 
majority of differentially expressed genes were found to have immune-associated functions, with 215 
other affected genes being involved in cellular metabolism, transcriptional and translational 216 
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regulation, apoptosis, and phagocytosis (51). Vijayakumar and colleagues (51) expanded on 217 
these findings by using Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathway analysis 218 
to refine the specific crow immunological pathways affected by HPAI infection (Figure 3). For 219 
instance, crows showed altered expression of multiple innate immune signalling pathways that 220 
are involved in viral recognition and influence activation of adaptive responses such as rig-1-like 221 
receptor (RLR) and Nod-like receptor (NLR) signalling pathways. Furthermore, infected crows 222 
demonstrated altered expression of genes involved in inflammation including cytokines and 223 
chemokines as well as adaptive immunity including TCR signalling (51). While gene expression 224 
analyses such as those obtained from HPAI-infected mallards and crows represent important 225 
advances in our understanding of the immune responses of wild birds to EIDs, they also 226 
highlight the complexity of these responses and the gaps in our understanding of the extent to 227 
which these responses allow the host to fight and/or clear infection.  228 
 229 
EVOLUTION OF AVIAN IMMUNITY TO EIDS: A CASE STUDY OF THE 230 
OUTBREAK OF MYCOPLASMA GALLISEPTICUM IN HOUSE FINCHES 231 
 232 
Evolution of resistance 233 
Few novel EID outbreaks in natural populations are as well documented as the Mycoplasma 234 
gallisepticum epizootic in North American house finches (52-56). M. gallisepticum, an endemic 235 
bacterial pathogen of poultry, was first detected in house finches in Maryland in 1994 (17). 236 
Although this bacterium readily switches hosts between chickens (Gallus gallus) and turkeys 237 
(Meleagridis gallapovo), a single lineage of poultry origin has since been confirmed to be 238 
responsible for the house finch outbreak (57) (58). In house finches, M. gallisepticum manifests 239 
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as an upper respiratory tract and eye (conjunctivitis) infection (59) that can lead to death, in part, 240 
through blindness-induced starvation and predation. Following reports of individuals with 241 
swollen eyes at birdfeeders, the Cornell Laboratory of Ornithology set up a Citizen Science 242 
program (http://www.birds.cornell.edu/hofi/), through which volunteer birdwatchers could report 243 
observations of diseased house finches (60). This allowed for thorough documentation of both 244 
temporal and spatial changes in disease prevalence over time (61). Within 4 years, M. 245 
gallisepticum had spread throughout house finch populations in the eastern United States, killing 246 
an estimated tens of millions of house finches (9, 62). Prevalence, however, subsequently 247 
declined from epizootic to apparent enzootic levels (54, 61), raising important questions 248 
regarding the possible evolution of resistance/tolerance in house finches and underlying changes 249 
in host immune processes. 250 
 251 
Investigations of host immune responses at epizootic onset, as well as how these responses 252 
subsequently evolved, is made possible in this system due to the persistence of unexposed house 253 
finch populations with which to compare infected populations (63). In 2007, Bonneaud et al. (63) 254 
experimentally infected wild-caught finches from disease-unexposed, western US (Arizona) 255 
populations and from disease-exposed, eastern US (Alabama) populations with M. gallisepticum 256 
to test whether resistance had spread in eastern house finch populations. After verification that 257 
the finches had never been naturally infected with M. gallisepticum, finches were either 258 
inoculated with a contemporary 2007-Alabama strain or sham-inoculated (controls). Two weeks 259 
post-infection, finches from disease-unexposed populations harboured nearly 50% greater 260 
bacterial loads than finches from exposed populations (Figure 4). Comparison of splenic 261 
transcriptional responses to infection of finches from unexposed versus exposed populations 262 
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measured before and after the apparent spread of host resistance, confirmed that disease-exposed 263 
house finch populations had evolved resistance to M. gallisepticum from standing genetic 264 
variation in only 12 years of disease exposure (63).  265 
 266 
Insights from studies in poultry 267 
M. gallisepticum is an economically-important bacterium known to infect a wide range of hosts 268 
of agricultural relevance (64), primarily chickens and turkeys. As a result, studies conducted in 269 
poultry have provided important insights into the pathogenesis of M. gallisepticum, as well as 270 
into the immune processes activated in the poultry host. These, in turn, improve our 271 
understanding of the host and pathogen processes taking place in the house finch host. As with 272 
other Mycoplasmas (65, 66), M. gallisepticum displays the ability to evade and manipulate the 273 
immune system of its hosts, with both potentiating and suppressive effects on various 274 
components of immunity (67).  Teasing apart the immune processes under host and pathogen 275 
control and their role in resolving or benefiting infection, is therefore challenging. However, 276 
insights into bacterial-driven processes can be obtained, for e.g., by comparing the immune 277 
responses elicited in poultry by closely related virulent and attenuated strains of M. gallisepticum 278 
(68).  279 
 280 
The establishment of infection (i.e., colonisation) by M. gallisepticum encompasses both 281 
adherence to host tissues and initial multiplication and occurs at the mucosal surface of the 282 
respiratory epithelium. This is made difficult by the presence of mucus and mucociliary 283 
clearance (69). Thus, to facilitate invasion, M. gallisepticum can use specific 284 
lipoproteins/lipopeptides that bind to host epithelial cells (66) and can induce a misdirected 285 
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inflammatory response that will disrupt the epithelial membrane (70, 71). Lesions in host tissues 286 
have been shown to result from the recruitment, activation and proliferation of heterophils and 287 
macrophages initially, and of lymphocytes subsequently, to and at the site of infection (72). 288 
Inoculations of chickens with virulent (Rlow) and attenuated (GT5) strains revealed that this 289 
leucocyte chemotaxis is achieved through the release of chemokines by infected tissues (68), 290 
including lymphotactin, CXCL13, CXCL14, RANTES, and macrophage inflammatory protein β 291 
1(MIP-1β) (68). MIP-1β secretion by chicken monocytes and macrophage-like cells was also 292 
confirmed in vitro (73) and shown to act as an attractant for many leucocytes, including 293 
heterophils, T lymphocytes and NK cells (73, 74). Such findings are consistent with the 294 
infiltration of non-specific CD8
+
TCR0 cells (most likely NK cells) in the tracheal mucosa of 295 
infected chickens, with infiltration peaking 1 week post-infection and thought to play an 296 
important role in disease progression through cytotoxicity (71, 72). Comparison of tracheal 297 
expression patterns following infection with Rlow and GT5 also confirmed that chickens up-298 
regulated pro-inflammatory cytokines (68), such as TNF-α and IL-6, which are responsible for 299 
local and systemic inflammation and can also give rise to tissue destruction and local necrosis. 300 
While the induction of an inflammatory response may therefore be beneficial to M. gallisepticum 301 
and facilitate invasion of the host (49, 75), persistence of infection may on the other hand 302 
necessitate the suppression of other components of immunity (71). Accordingly, chickens 303 
infected with Rlow down-regulated the tracheal expression of the chemokine CCL20 and 304 
cytokines IL-8, IL-1β and IL-12p40 as early as 1 day post-inoculation (68). The fact that these 305 
cytokines are also involved in key inflammatory processes (76) highlights the complexity of 306 
pathogen-mediated manipulation of the host immune system. Furthermore, chickens infected 307 
with M. gallisepticum displayed lower T-cell activity 2 weeks post-infection (70, 72) and lower 308 
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humoral responses against Haemophilus gallinarum (77) or against avian pneumovirus (78) 309 
when co-inoculated with M. gallisepticum. The ability of M. gallisepticum to limit humoral and 310 
T-cell responses may be crucial for disease progression, as both local antibody-mediated 311 
responses and natural killer and cytotoxic T-cell responses have been suggested to play a role in 312 
controlling infection in chickens (71).   313 
 314 
Immune processes in the house finch host 315 
Comparison of transcriptional changes in the spleen of infected house finches from disease-316 
unexposed/susceptible and exposed/resistant populations revealed significant differences as early 317 
as three days post-infection (79), indicating that the evolution of resistance in exposed 318 
populations involved changes in innate immune processes. Two-weeks post-infection, 319 
susceptible finches from unexposed populations down-regulated immune-associated genes and, 320 
relative to infected finches from exposed populations, exhibited significantly lower levels of 321 
transcripts of the following genes (79): T-cell immunoglobulin and mucin domain containing 4 322 
(tim4), MHC-class II-associated invariant chain I1 (cd74), lectin galactoside-binding soluble-2 323 
(lgals2), programmed death ligand 1 (pd-l1), TCR beta chain (tcrβ), immunoglobulin J (IgJ), 324 
neutrophil cytosolic factor-4 (ncf4), immunoglobulin superfamily member 4A (Igsf4A) and 325 
parathymosin (ptms). The only exception was the complement factor-H (hCG40889) gene, 326 
whose expression was up-regulated in infected finches from unexposed populations. However, 327 
because hCG40889 is known to restrict activation of the complement cascade (80), the overall 328 
expression patterns detected suggest that particular components of the immune system were 329 
being suppressed in finches from unexposed populations. Infected finches from exposed 330 
populations, on the other hand, were able to up-regulate the expression of immune-associated 331 
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genes two-weeks post-infection (79). Three of the genes up-regulated were: TIM4, which is 332 
involved in the differentiation of naïve CD4+ T cells into Th2 cells and which plays a role in 333 
preventing autoimmunity by mediating the clearance of apoptotic (phosphatidylserine-334 
expressing) antigen-specific T cells after infection (81); CD74, which plays a role during the 335 
assembly of MHC class II molecules (82); NCF4 which plays a role in phagocytosis-induced 336 
oxidant production in heterophils (83). Taken together, these finding suggests that finches from 337 
disease-exposed populations have evolved the ability to resist pathogen-induced immuno-338 
suppression and supports a role of both innate (e.g., phagocytosis by heterophils) and acquired 339 
(e.g., T-cell activity) immune processes in mediating resistance to pathogen spread (79). 340 
 341 
Protective immunity is expected to evolve only when the costs of resisting infection are lower 342 
than those incurred by the infection itself (84, 85). Surprisingly, resistance to M. gallisepticum 343 
was found to have evolved despite the fact that the short-term energetic costs of immunity were 344 
greater than those of pathogenesis (86). Disentangling the costs attributable to immune 345 
functioning from those incurred from the parasite’s presence is challenging in in vivo infection 346 
studies involving real pathogens (87). As a result, most of our understanding of the costs of 347 
immunity stems from studies using inert pathogens (88). However, two unusual features of the 348 
M. gallisepticum-house finch interaction permitted such a study in this system. First, it is 349 
possible to compare the response to infection between finches that are either susceptible or 350 
resistant depending on their population of origin (i.e., disease-unexposed or –exposed 351 
populations, respectively) (63, 89). Second, only resistant finches from disease-exposed 352 
populations are able to mount a protective immune response, as demonstrated both by the greater 353 
bacterial load and the overall down-regulation of immune-associated genes at early as 3 days 354 
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post-infection in finches from unexposed populations (63, 79). It is important to note, however, 355 
that genes associated with innate immunity, and in particular with inflammation, were not 356 
specifically examined in this study and hence may have been up-regulated in finches from 357 
unexposed populations at the start of the infection. This hypothesis is supported by the findings 358 
of Hawley and colleagues (90) showing increased levels of IL-6 in house finches 2 days post-359 
inoculation with M. gallisepticum, as well as a 2°C increase in body temperature 1 day post-360 
infection with a ~1°C increase persisting over the entire 2-weeks duration of the experimental 361 
infection. Regardless, the greater susceptibility of finches from disease-unexposed population 362 
implies that any potential inflammatory response was not protective and therefore likely reflectes 363 
pathogenesis. 364 
 365 
As expected based on the findings above, infected finches from disease-exposed populations  lost 366 
10 times more body mass over the course of two-weeks than uninfected controls from the same 367 
populations, revealing a cost of immunity (86) (Figure 5a). Furthermore, infected individuals 368 
from the disease-exposed population that lost the most mass and displayed immune-associated 369 
gene expression patterns in a direction consistent with greatest protective immunity (i.e., 370 
resistance) against M. gallisepticum, also harboured the lowest pathogen loads in their 371 
conjunctivae (Figure 5b). Conversely, infected finches from disease-unexposed populations lost 372 
twice as much body mass as their controls, although this difference was marginal. In addition, in 373 
this population, infected individuals that lost the most mass harboured the greatest bacterial load 374 
in their conjunctivae, indicating a measurable cost of pathogenesis. Interestingly, the mass lost 375 
by infected birds differed significantly between populations, with mass loss being greater in 376 
infected finches from exposed populations (Figure 5). This indicates that counter to predictions, 377 
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the short-term energetic costs of immunity were greater than those of pathogenesis (86). These 378 
results therefore highlight the fact that resistance can evolve despite this, provided the fitness 379 
consequences of infection are sufficiently detrimental to the host. 380 
 381 
Evolution of tolerance 382 
The consequences of pathogen-driven selection on host evolution in this system are made all the 383 
more interesting by the fact that resistance was not the only host trait to evolve following 384 
epizootic outbreak. Adelman and colleagues (89) demonstrated that pathogen tolerance,  which is 385 
the ability to limit the damage incurred from a given pathogen load (91), also spread in eastern 386 
house finch populations following disease exposure. To this end, they caught finches from 387 
unexposed western US (Arizona) and exposed eastern US (Alabama) populations in 2010 and 388 
experimentally infected them with an M. gallisepticum isolate collected in Virginia in 1994 (i.e., 389 
at epizootic onset). Given that exposed populations were shown to have evolved resistance to M. 390 
gallisepticum between 2001 and 2007 (63), infection with an isolate sampled 16 years earlier 391 
ensured that any immunomodulatory effects of the bacteria would be minimised. Tolerance was 392 
then assessed using peak levels of pathology (i.e., eye lesions and mass loss) and bacterial load, 393 
as well as measures of pathology and bacterial load that incorporated infection duration and 394 
intensity (i.e., by measuring the area under the curves of pathology and pathogen load over time). 395 
Results showed that finches from the unexposed population had significantly greater peak eye 396 
lesions and mass loss than finches from the exposed population despite similar peak pathogen 397 
load. In addition, eye lesions also peaked a week later in finches from the exposed population 398 
relative to the unexposed one (89) (e.g., peak eye score; unexposed: 4.13±0.48 on day 7; 399 
exposed=5.79±0.14 on day 14) (Figure 6). 400 
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 401 
The heightened tolerance of finches from the M. gallisepticum-exposed population was 402 
associated with a lower inflammatory response to infection relative to finches from the 403 
unexposed population (89). Specifically, finches from exposed populations displayed 404 
significantly lower levels of IL-1β, but marginally higher levels of IL-10, 24-hours post-infection 405 
(89) (Figure 7). IL-1β is a pro-inflammatory cytokine secreted by macrophages and that plays a 406 
key role in the acute phase response (76). The difference in the expression of IL-1β between 407 
finches from exposed and unexposed populations thus is likely to be responsible for the delayed 408 
and lowered febrile responses of the former (89) (increase in body temperature on day 1 post-409 
infection; exposed: 0.71°±0.03°C; unexposed:1.44°±0.18°C). 410 
 411 
While resistance and tolerance are often thought of as two alternative evolutionary responses to 412 
pathogen-driven selection (91, 92), studies on the house finch-M. gallisepticum system indicate 413 
that this may not necessarily be the case and that both processes can evolve in conjunction to 414 
reduce the overall fitness consequences of infection (63, 89). Interestingly, that tolerance reduced 415 
both inflammation and the severity of clinical symptoms (i.e., eye lesions and mass loss) without 416 
decreasing pathogen load (89) suggests that infection success is not necessarily positively 417 
correlated with the level of immunopathology suffered by the host. As a result, the extent to 418 
which host lesions can be minimised without impacting pathogen colonisation success or 419 
persistence will determine the relative contribution of resistance and tolerance to the 420 
evolutionary response of house finches to M. gallisepticum, with significant ramifications for the 421 
evolution of pathogen virulence (91).  422 
 423 
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CONCLUSION 424 
Wild birds have been shown to mount immune responses to emerging infectious pathogens, but 425 
these responses are not always associated with reduced severity, or even absence, of clinical 426 
symptoms, nor do they necessarily allow the host to clear and survive the infection. The extent to 427 
which these immune responses help to fight novel pathogens, however, seems dependent on the 428 
type of response elicited, with humoral responses conferring some level of protection and 429 
inflammatory responses being associated with increased disease severity. The extent to which 430 
immune processes allow the host to fight the infection or, on the opposite, facilitate disease 431 
progression will have important consequences for the evolution of immune responses over time 432 
in response to pathogen-mediated selection. In cases where inflammation underlies disease 433 
pathology, a lack of immune responsiveness with or without the involvement of other 434 
components of immunity (e.g., humoral immunity) may be favoured by natural selection, thus 435 
leading to the evolution of tolerance and/or resistance. The combined spread of tolerance and 436 
resistance to EIDs appears to have occurred in house finches following the outbreak of the 437 
conjunctivitis-causing M. gallisepticum. Whether this evolutionary change was mediated solely 438 
by changes in the finches’ inflammatory response, with important consequences for more 439 
pathogen-specific components of immunity (e.g., T cell and humoral immunity), or whether host 440 
evolution has occurred through parallel changes in multiple components of immunity (e.g., 441 
inflammation and T cell immunity concurrently) remains to be determined. Finally, further 442 
insights into the role of different immune processes can be gained from detailed inter- and intra-443 
specific comparisons linking immune responses to EIDs at a molecular and cellular level with 444 
variation in disease progression and outcome. By increasing our understanding of the role of host 445 
immune responses in EID outbreaks and persistence, studies conducted on wild bird populations 446 
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will have the potential to improve our predictions of species particularly at risk of infection by 447 
EIDs. 448 
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BOX 1: The emerging infectious diseases (EIDs) of wild birds discussed in this review (ordered 740 
chronologically). 741 
 742 
Plasmodium relictum – P. relictum, a protist responsible for causing avian malaria, is among the 743 
earliest documented EIDs known to significantly affect wild birds. Following the accidental 744 
introduction of its mosquito vector, Culex quinquefasciatus, to the Hawaiian islands in the early 745 
20
th
 century, this novel disease devastated local populations of honeycreepers including the 746 
apapane (Himatione sanguinea), Hawaii amakihi (Hemignathus virens), and iiwi (Vestiaria 747 
coccinea) and contributed to the extinction of several others. As a result many native Hawaiian 748 
birds could only be found in large numbers in high elevation forests and islands that were free of 749 
mosquitos (14, 31). However, based on mist-netting surveys conducted on the island of Hawaii 750 
in 2002, Hawaii amakihi have persisted and increased in abundance at low elevations where P. 751 
relictum is prevalent, such that Hawaii amakihi are more abundant at low elevations than at high 752 
elevations (93). Furthermore, these populations have been shown to be genetically isolated from 753 
high elevation populations (94), creating a unique system in which the evolution of host 754 
immunity to EIDs can be examined (95).  755 
 756 
Mycoplasma gallisepticum – In 1994, the poultry pathogen M. gallisepticum was found to be the 757 
causative agent of a novel conjunctivitis disease observed in house finches (Haemorhous 758 
mexicanus) in Maryland, United States. Within 3-4 years this bacterial pathogen spread 759 
throughout the entire eastern range of the house finch in North America killing an estimated tens 760 
of millions of house finches. These deaths resulted in part from the manifestation of M. 761 
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gallisepticum as a respiratory disease as well and in part from the conjunctivitis-induced 762 
blindness leading to starvation and increased susceptibility to predation (9, 17, 18, 61, 96).  763 
 764 
West Nile Virus - In 1999, a novel highly pathogenic strain of West Nile Virus was found to be 765 
responsible for the unusually high numbers of bird deaths in New York (NY), United States (19, 766 
97-99). While some affected birds displayed no symptoms before death, the most affected 767 
species such as American crows (Corvus brachyrhynchos) displayed severe symptoms including 768 
anorexia, weakness, and mass loss as well as neurological problems such as ataxia, tremors, 769 
circling, disorientation, and impaired vision resulting from WNV-induced encephalitis (21). 770 
Sequence analysis of WNV isolates from this epidemic found NY-1999 WNV isolates to be most 771 
closely related to WNV isolated from a dead goose in Israel in 1998 (100). Combined with a lack 772 
of evidence for WNV in the United States before 1999, the epidemic was likely the result of a 773 
novel introduction of WNV to the US with a probable Mediterranean origin (99-101).  774 
 775 
Highly pathogenic avian influenza (HPAI) virus – Historically waterfowl have been 776 
considered asymptomatic carriers of avian influenza viruses. However, H5N1 HPAI was found 777 
to be responsible for the deaths of new and old world species of ducks, geese, and swans in two 778 
Hong Kong parks between December 2002 and January 2003. Affected birds exhibited 779 
symptoms ranging from slight inactivity, inappettence, and ruffled feathers to severe 780 
neurological symptoms including paresis, paralysis, tremors, and unusual head tilt, with death 781 
often occurring within 24 hours of the onset of symptoms (15). Indeed, H5N1 isolates collected 782 
during the outbreak were found to cause systemic disease and similar severe clinical symptoms 783 
in mallards (Anas platyrhychos) whereas 1997 and 2001 H5N1 isolates from Hong Kong did not 784 
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(102). Subsequent outbreaks of HPAI affecting waterfowl occurred in China (103, 104), Japan 785 
(105) Bangladesh (106) as well as numerous European countries in 2006 (107, 108).  786 
 787 
Trichomonas gallinae – In 2005, a clonal strain of the protozoan T. gallinae spread from wild 788 
columbiform birds to chaffinches (Fringilla coelebs) and greenfinches (Carduelis chloris) in 789 
Great Britain, causing the loss of an estimated half a million birds by 2007 (16). While chaffinch 790 
populations began to stabilize, greenfinch populations further declined, with an estimated 791 
population decrease from 4.3 to 2.8 million, or overall 1.5 million, greenfinches by 2009 (13). 792 
Since then, T. gallinae has spread to finches in other European countries including Norway, 793 
Sweden, and Finland (45) and has been found to cause disease in raptors including 794 
sparrowhawks (Accipiter nusis) and tawny owls (Strix aluco), presumably due to consumption of 795 
infected finches (109).   796 
  797 
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FIGURE LEGENDS 798 
 799 
Figure 1: Using experimental WNV infections in American crows (Corvus brachyrnchos) and 800 
fish crows (Corvus ossifragus), Nemeth and colleagues (39) show differences in disease 801 
progression and outcome between these two species that may be associated with differences in 802 
humoral immune responses. (Modified from (39)) 803 
Figure 2: Severity of H5N1 HPAI encephalitis in nine naturally infected wild bird species: mute 804 
swans (Cygnus olor), Canada geese (Branta Canadensis), greater scaup (Aythya marila), 805 
European eagle owls (Bubo bubo), tufted duck (Aythya fuligula), goosander (common 806 
merganser; Mergus merganser), common buzzard (Buteo buteo), smew (Mergellus albellus), and 807 
herring gull (Larus argentatus). Severity is based on use of immunohistochemistry to assess 808 
intensity and area of staining for the following: total area of inflammation, inflammatory 809 
components, viral antigen prevalence, neuronal changes, and vascular changes. (From (46)) 810 
 811 
Figure 3: KEGG pathway analysis of differentially expressed genes in the lungs of non-infected 812 
versus HPAI-infected jungle crows (Corvus macrorhynchos). (From (51)) 813 
 814 
Figure 4: Symptoms of M. gallisepticum infection and pathogen load in the conjunctivae of 815 
house finches. A) Symptoms of M, gallisepticum infection in naturally infected (Left) and 816 
healthy (Right) wild house finches. (B) Quantification of bacterial load in the conjunctiva of 817 
infected finches from disease-exposed and unexposed populations, 2 weeks post-infection. (From 818 
(63)). 819 
 820 
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Figure 5: Mass loss in M. gallisepticum-infected house finches vs. sham-inoculated controls, and 821 
bacterial load in the conjunctivae of infected finches. (a) Effects of infection with M. 822 
gallisepticum vs. sham inoculations on mass change (g) between days 0 and 14 post-infection in 823 
finches from disease-exposed (Alabama) and disease-unexposed (Arizona) populations. (b) 824 
Association between bacterial load 14 days post-infection and mass change (g) between days 0 825 
and 14 post-infection in birds from Alabama (open squares) and Arizona (filled diamonds). 826 
(From (86)). 827 
 828 
Figure 6: Pathology of house finches infected with M. gallisepticum and originating either from 829 
disease-exposed (Alabama) or disease-unexposed (Arizona) populations. Finches from the 830 
exposed population displayed lower peak eye lesion score (a) and reduced mass loss (b) relative 831 
to finches from unexposed populations, despite similar bacterial load (c). (From (89)). 832 
 833 
Figure 7: Expression of the inflammatory cytokines in the blood of house finches infected with 834 
M. gallisepticum and originating either from disease-exposed (Alabama) or disease-unexposed 835 
(Arizona) populations. Expression of the pro-inflammatory cytokine IL-1β was significantly 836 
lower in finches from the exposed population (a), but expression of the anti-inflammatory 837 
cytokine IL-10 was marginally higher in those individuals relative to those from the unexposed 838 
population (b). (From (89)). 839 
  840 
40 
 
Figure 1 841 
 842 
  843 
41 
 
Figure 2 844 
 845 
  846 
42 
 
Figure 3 847 
848 
43 
 
Figure 4 849 
(a) 850 
 851 
 852 
(b) 853 
 854 
 855 
 856 
 857 
  858 
44 
 
1 
 
0 
 
-1 
 
-2 
 
-3 
 
-4 
 
-5 
 
-6 
Alabama Arizona
ma
Figure 5 859 
(a)               (b) 860 
 861 
 862 
  863 
45 
 
Figure 6 864 
(a)       (b) 865 
 866 
 867 
 868 
 869 
 870 
 871 
(c) 872 
  873 
46 
 
Figure 7 874 
(a)        (b) 875 
 876 
